Mehmet Ozturk

Cited by

	All	Since 2019
Citations	12099	1855
h-index	50	23
i10-index	97	41

480

240

120

360

198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202435 32 54 119 324 378 408 424 327 342 313 346 359 335 375 324 330 323 374 324 321 318 330 416 418 431 470 434 361 370 380 372 338 403 310 249 182

Public access

View all

12 articles

1 article

available

not available

Based on funding mandates

Co-authors

Rengul Cetin AtalayUniversity of ChicagoVerified email at uchicago.edu
Bressac BrigitteMolecular Geneticist, Gustave Roussy, Paris-Saclay UniversityVerified email at gustaveroussy.fr
Serif SenturkProfessor at Dokuz Eylul University & Group Leader at Izmir Biomedicine and Genome CenterVerified email at ibg.edu.tr
Dominique BELLETProfesseur d'immunologie, Université Paris DescartesVerified email at parisdescartes.fr
Ozge gursoy YuzugulluDana Farber Cancer Institute, Harvard Medical SchoolVerified email at dfci.harvard.edu
Kurt J IsselbacherDirector Emeritus, Massachusetts General Hospital Cancer CenterVerified email at mgh.harvard.edu
Esra ErdalIzmir Biomedicine and Genome Center ; Dokuz Eylul University, Faculty of MedicineVerified email at ibg.edu.tr
HALUK YUZUGULLUAstrazeneca PharmaceuticalsVerified email at astrazeneca.com
Frederique PonchelThe University of Leeds (LIRMM, TRIMID)Verified email at leeds.ac.uk
Kamil Can AkcaliTıp Fakültesi Profesörü, Ankara ÜniversitesiVerified email at ankara.edu.tr
Cigdem Ozen, Ph.D.TU Dresden, Bioinformatics, Center for Molecular and Cellular Bioengineering (CMCB)Verified email at tu-dresden.de
YAKICIERProfessor of Molecular Biology and Genetics ACIBADEM UniversityVerified email at acibadem.com.tr
Hiroshi TakahashiTexas Instruments JapanVerified email at ti.com
Caroline Moyret-LalleUniversité Claude Bernard Lyon 1Verified email at lyon.unicancer.fr
Nuri OzturkProfessor @ Gebze Technical UniversityVerified email at gtu.edu.tr
Neşe ATABEYIzmir Biyotıp ve Genom Merkezi & İzmir Tınaztepe Üniversitesi Tıp FakültesiVerified email at ibg.edu.tr
Gokhan YildizKaradeniz Technical University School of Medicine Department of Medical BiologyVerified email at ktu.edu.tr
Ayça Arslan ErgülUNAM, Bilkent UniversityVerified email at bilkent.edu.tr
Rachidi walidUniveristé GRENOBLE AlpesVerified email at univ-grenoble-alpes.fr
Tamer YagciVerified email at gyte.edu.tr

Mehmet Ozturk

Izmir Tinaztepe University

Verified email at tinaztepe.edu.tr

Molecular Biology Genetics Cell Biology Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Selective G to T mutations of p 53 gene in hepatocellular carcinoma from southern Africa B Bressac, M Kew, J Wands, M Ozturk Nature 350 (6317), 429-431, 1991	1870	1991
p53 functions as a cell cycle control protein in osteosarcomas L Diller, J Kassel, CE Nelson, MA Gryka, G Litwak, M Gebhardt, B Bressac, ... Molecular and cellular biology 10 (11), 5772-5781, 1990	1078	1990
p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991	641	1991
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma B Bressac, KM Galvin, TJ Liang, KJ Isselbacher, JR Wands, M Ozturk Proceedings of the National Academy of Sciences 87 (5), 1973-1977, 1990	583	1990
Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway JP Rouault, N Falette, F Guéhenneux, C Guillot, R Rimokh, Q Wang, ... Nature genetics 14 (4), 482-486, 1996	523	1996
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens A Puisieux, S Lim, J Groopman, M Ozturk Cancer research 51 (22), 6185-6189, 1991	390	1991
Human MLH1 deficiency predisposes to hematological maligancy and neurofibromatosis type 1 MD Ricciardone, T Özçelik, B Cevher, H Özdağ, M Tuncer, A Gürgey, ... Cancer research 59 (2), 290, 1999	318	1999
Systems medicine and integrated care to combat chronic noncommunicable diseases J Bousquet, JM Anto, PJ Sterk, IM Adcock, KF Chung, J Roca, A Agusti, ... Genome Medicine 3 (7), 1-12, 2011	314	2011
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ... Molecular cancer 8, 1-20, 2009	309	2009
Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth S Senturk, M Mumcuoglu, O Gursoy‐Yuzugullu, B Cingoz, KC Akcali, ... Hepatology 52 (3), 966-974, 2010	275	2010
Genetic aspects of hepatocellular carcinogenesis. M Ozturk Seminars in liver disease 19 (3), 235-242, 1998	256	1998
Evaluation of cytotoxicity and oxidative DNA damaging effects of di (2-ethylhexyl)-phthalate (DEHP) and mono (2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and … P Erkekoglu, W Rachidi, OG Yuzugullu, B Giray, A Favier, M Ozturk, ... Toxicology and applied pharmacology 248 (1), 52-62, 2010	248	2010
Smad2 and Smad4 gene mutations in hepatocellular carcinoma MC Yakicier, MB Irmak, A Romano, M Kew, M Ozturk Oncogene 18 (34), 4879-4883, 1999	238	1999
Genetic heterogeneity of hepatocellular carcinoma H Unsal, C Yakicier, C Marcais, M Kew, M Volkmann, H Zentgraf, ... Proceedings of the National Academy of Sciences 91 (2), 822-826, 1994	225	1994
PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways E Demir, O Babur, U Dogrusoz, A Gursoy, G Nisanci, R Cetin-Atalay, ... Bioinformatics 18 (7), 996-1003, 2002	216	2002
Redundant expression of canonical Wnt ligands in human breast cancer cell lines K Benhaj, KC Akcali, M Ozturk Oncology reports 15 (3), 701-707, 2006	204	2006
Physiological studies of human chorionic gonadotropin (hCG), αhCG, and βhCG as measured by specific monoclonal immunoradiometric assays M OZTURK, D BELLET, LUC MANIL, G HENNEN, R FRYDMAN, ... Endocrinology 120 (2), 549-558, 1987	170	1987
Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines A Puisieux, K Galvin, F Troalen, B Bressac, C Marcais, E Galun, ... The FASEB journal 7 (14), 1407-1413, 1993	166	1993
P53 mutation as a source of aberrant β-catenin accumulation in cancer cells T Cagatay, M Ozturk Oncogene 21 (52), 7971-7980, 2002	148	2002
Senescence and immortality in hepatocellular carcinoma M Ozturk, A Arslan-Ergul, S Bagislar, S Senturk, H Yuzugullu Cancer letters 286 (1), 103-113, 2009	122	2009

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors